The first seminal observations of the potential role of Glo1 in PCa onset were made later by Davidson et al. [107] who performed a quantitative PAGE-based Glo1 assay on 22 PCa and ten normal prostate tissues to assess its activity, and thereby establish its clinical importance in this neoplasm. This evidence concerns the gene GLO1 and posterior cortical atrophy.